Eris Lifesciences has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 12, 2018, to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended December 31, 2017. Further, pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015 and Policy on code of conduct to regulate, monitor and report trading by Insiders of the Company, the Trading Window for dealing in shares of the Company will remain closed from February 5, 2018 to February 14, 2018 for the purpose of this Board Meeting and the same has been notified to the Designated Persons.
The above information is a part of company’s filings submitted to BSE.
